SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-22-101186
Filing Date
2022-09-19
Accepted
2022-09-19 16:30:26
Documents
12
Period of Report
2022-01-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A tm2226080d1_8ka.htm   iXBRL 8-K/A 26007
  Complete submission text file 0001104659-22-101186.txt   200085

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA imrx-20220114.xsd EX-101.SCH 3042
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE imrx-20220114_lab.xml EX-101.LAB 34476
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imrx-20220114_pre.xml EX-101.PRE 22601
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2226080d1_8ka_htm.xml XML 3767
Mailing Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142
Business Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142 617-500-8080
Immuneering Corp (Filer) CIK: 0001790340 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-40675 | Film No.: 221250919
SIC: 2834 Pharmaceutical Preparations